Learn more

Adelaide res & innovation pty ltd

Overview
  • Total Patents
    108
  • GoodIP Patent Rank
    30,176
  • Filing trend
    ⇩ 88.0%
About

Adelaide res & innovation pty ltd has a total of 108 patent applications. It decreased the IP activity by 88.0%. Its first patent ever was published in 1991. It filed its patents most often in Australia, United States and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are UVIC INDUSTRY PARTNERSHIPS INC, PONTIFICIA UNIV CATÓLICA DE CHILE and AIRWAY THERAPEUTICS INC.

Patent filings per year

Chart showing Adelaide res & innovation pty ltds patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Hoffmann Peter 11
#2 Monro Tanya 6
#3 Smyth Mark 6
#4 Mccoll Shaun Reuss 6
#5 Comerford Ian 6
#6 Ebendorff-Heidepriem Heike 6
#7 Harata-Lee Yuka 6
#8 Fitter Stephen 5
#9 Wirthensohn Michelle 5
#10 Gronthos Stan 5

Latest patents

Publication Filing date Title
WO2017214684A1 Methods and products for identifying conditions associated with cardiac fibrotic remodelling
WO2017210749A1 Methods and products for treating autoimmune diseases
WO2017185142A1 Method for preventing and/or treating atrial fibrillation
CA2986791A1 Methods and products for enriching and isolating stem cells
WO2016191802A1 Composite graphene-based material
US2017347510P1 Almond variety named ‘CAPELLA’
US2017347508P1 Almond variety named ‘RHEA’
US2017347512P1 Almond variety named ‘CARINA’
US2017347511P1 Almond variety named ‘MAXIMA’
US2017347509P1 Almond variety named ‘MIRA’
US2018114600A1 Methods and systems for determining risk of a pregnancy complication occurring
AU2015330V Rhea Prunus dulcis
AU2015332V Capella Prunus dulcis
AU2015329V Carina Prunus dulcis
AU2015331V Mira Prunus dulcis
AU2015328V Maxima Prunus dulcis
AU2015402240A1 Multiple transducer method and system for pipeline analysis
US2016291025A1 Autoantibody biomarkers of ovarian cancer
AU2014262132A1 Dual wavelength pumped laser system and method
US2015291698A1 Methods and products for preventing and/or treating metastatic cancer